Advertisement

Abstract

The soft-tissue sarcomas (STS) of childhood are a relatively rare and heterogeneous group of tumors that may occur anywhere in the body and respond quite differently to therapy. STSs account for 7.4% of all cancers in children younger than 20 years [1]. These soft tissue sarcomas are divided almost equally between rhabdomyosarcomas originating from striated muscle and nonrhabdomyosarcoma soft tissue sarcomas (NRSTS). Sarcomas are malignant tumors of mesenchymal cell origin. They are named according to the normal tissue they resemble — for example, rhabdomyosarcoma (skeletal muscle), leiomyosarcoma (smooth muscle), and fibrosarcoma and malignant fibrous histiocytoma (connective tissue), neurofibrosarcoma or malignant peripheral nerve sheath tumor (neurofibrosarcomas, as seen in patients with neurofibromatosis), liposarcoma (adipose), synovial sarcoma (synovium), peripheral nerve sheath tumors (peripheral nerve), and angiosarcoma (blood and/or lymphatic vessels). Other sarcomas include rare entities such as alveolar softpart sarcoma, extraosseous Ewing’s sarcoma, peripheral neuroectodermal tumors, epitheloid sarcoma, and hemangiopericytoma.

Keywords

Clin Oncol Clinical Group Synovial Sarcoma Malignant Peripheral Nerve Sheath Tumor Sentinel Lymph Node Mapping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gurney JG, Young JL, Roffers SD, et al. (1999) Soft tissue sarcomas. In: Gloecker Ries IA, Smith MA, Gurney JG, et al. (eds) SEER Pediatric Monograph: Cancer incidence and survival among children and adolescents, United States SEER program 1975–1995. National Cancer Institute, Bethesda, pp 111–124Google Scholar
  2. 2.
    Ruymann FB, et al. (1991) Epidemiology of soft tissue sarcomas. In: Maurer HM, Ruymann FB, Pochedly C (eds) Rhabdomyosarcoma and related tumors in children and adolescents. CRC Press, Boca RatonGoogle Scholar
  3. 3.
    Hayes-Jordan AA, Spunt SL, Poquette CA, et al. (2000) Nonrhabdomosarcoma soft tissue sarcomas in children: Is age at diagnosis an important variable? J Pediat Surg 35:948–953PubMedCrossRefGoogle Scholar
  4. 4.
    Laskin WH, Silverman IA, Enzinger JM (1988) Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer 62:2330–2340PubMedCrossRefGoogle Scholar
  5. 5.
    Cha C, Antonescu CR, Quan MI, et al. (2004) Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg 239:903–909PubMedCrossRefGoogle Scholar
  6. 6.
    Malkin D ( 1993) p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogent 66:83–92CrossRefGoogle Scholar
  7. 7.
    Malkin D, Li FP, Strong LC (1990) Germ line p53 mutations in a familial syndrome of breast cancer sarcomas, and other neoplasms. Science 250:1233–1238PubMedCrossRefGoogle Scholar
  8. 8.
    Glover IW, Stein CK, Legius F, et al. (1991) Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 3:62–70PubMedCrossRefGoogle Scholar
  9. 9.
    Ducatman BS, Scheithauer BW, Piepgras DG, et al. (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006–2021PubMedCrossRefGoogle Scholar
  10. 10.
    Evans DG, Baser ME, McGaughran J, et al. (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis l. J Med Genet 39:311–314PubMedCrossRefGoogle Scholar
  11. 11.
    Neville HL, Seymour-Dempsey K, Slopis J, et al. (2001) The role of surgery in children with neurofibromatois. J Pediat Surg 36:25–29PubMedCrossRefGoogle Scholar
  12. 12.
    Neville H, Lorpron C, Blakely M, Andrassy RJ (2003) Pediatric neurofibrosarcoma. J Pediat Surg 38:343–346PubMedCrossRefGoogle Scholar
  13. 13.
    Clark SK, Neale KF, Landgrebe JC, et al. (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185–1189PubMedCrossRefGoogle Scholar
  14. 14.
    Heiskanen I, Jarvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and results of treat. Int J Colorectal Dis 11:157–162PubMedCrossRefGoogle Scholar
  15. 15.
    Gurbuz AK, Giardiello FM, Petersen GM, et al. (1994) Desmoid tumours in familiar adenomatour polyposis. Gut 35:377–381PubMedCrossRefGoogle Scholar
  16. 16.
    Sreekantaiah C, Ladanyi M, Rodriguez E, et al. (1994) Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144:1121–1134PubMedGoogle Scholar
  17. 17.
    Limon J, Mrozek K, Mandahl N, et al. (1991) Cytogenetics of synovial sarcoma: Presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3:338–345PubMedCrossRefGoogle Scholar
  18. 18.
    Clark J, Rocques PI, Crew AJ, et al. (1995) Identification of novel genes, SYT to tow genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14:2333–2340PubMedGoogle Scholar
  19. 19.
    Crew AJ, Clark J, Fisher C, et al. (1995) Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14:2333–2340PubMedGoogle Scholar
  20. 20.
    Kawai A, Woodruff J, Healey JH, et al. (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338:153–160PubMedCrossRefGoogle Scholar
  21. 21.
    Nilsson G, Skytting B, Xie Y, et al. (1999) The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 59:3180–3184PubMedGoogle Scholar
  22. 22.
    Aman P, Ron D, Mandahl N, et al. (1992) Rearrangement of the transcription factor gene CHOP in myxoid kiposarcomas with t(12; 16) (q 13; p11). Genes Chromosomes Cancer 5:278–285PubMedCrossRefGoogle Scholar
  23. 23.
    Crozat A, Aman P, Mandahl N, et al. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640–644PubMedCrossRefGoogle Scholar
  24. 24.
    Barr FG, Chatten J, D’Cruz CM, et al. (1995) Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273:553–557.PubMedCrossRefGoogle Scholar
  25. 25.
    Ohno T, Ouchida M, Lee Il, et al. (1944) The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9:3087–3097Google Scholar
  26. 26.
    Li FP, Fraumeni JF Jr (1969) Rhabdomyosarcoma in children: Epidemiologie study and identification of a familial cancer syndrome. J Natl Cancer Inst 43:1365–1373PubMedGoogle Scholar
  27. 27.
    Li FP, Fraumeni JF Jr (1982) Prospective study of a family cancer syndrome. JAMA 247:2692–2694PubMedCrossRefGoogle Scholar
  28. 28.
    Knudson AG Jr (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437–1443PubMedGoogle Scholar
  29. 29.
    Orkin S (1986) Reverse genetics and human disease. Cell 47:845–850PubMedCrossRefGoogle Scholar
  30. 30.
    D’agostino An, Soule EH, Miller RH (1963) Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (von Recklinghausens disease). Cancer 16:1003–1014PubMedCrossRefGoogle Scholar
  31. 31.
    Diagostino An, Soule EH, Miller RH (1963) Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (von Recklinghausen’s disease). Cancer 16:1015–1027CrossRefGoogle Scholar
  32. 32.
    Storm FK, Eilber IR, Mirra J, et al. (1980) Neurofibrosarcoma. Cancer 45:126–129PubMedCrossRefGoogle Scholar
  33. 33.
    Guccion JG, Enzinger JM (1979) Malignant schwannoma associated with von Recklinghausen’s neurofibromatosis. Virchows Arch A Pathol Anat Histol 383:43–57PubMedCrossRefGoogle Scholar
  34. 34.
    Fienman Nil, Yakovac WC (1970) Neurofibromatosis in childhood. J Pediatr 76:339–346PubMedCrossRefGoogle Scholar
  35. 35.
    McLoughlin LC, Nord KS, Joshi VV, et al. (1991) Disseminated leiomyosarcoma in a child with acquired immune deficiency syndrome. Cancer 67:2618–2621PubMedCrossRefGoogle Scholar
  36. 36.
    McClain KI, Leach CT, Jenson IIB, etal. (1995) Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl Med 332:12–18CrossRefGoogle Scholar
  37. 37.
    Shen SC, Yunis FJ (1976) Leiomyosarcoma developing in a child during remission of leukemia. J Pediatr 89:780–782PubMedCrossRefGoogle Scholar
  38. 38.
    Swanson PF, Dehner IP (1991) Pathology of soft tissue sarcomas in children and adolescents. In: Maurer HM, Ruymann IB, (eds) Rhabdomyosarcoma and related tumors in children and adolescents. CRC Press, Boca Raton, 385–420Google Scholar
  39. 39.
    Andrassy RJ (2002) Advances in the surgical management of sarcomas in children. Amer J Surg 184:484–491PubMedCrossRefGoogle Scholar
  40. 40.
    Andrassy RJ, Okeu MF, Despa S, Raney RB (2001) Synovial sarcoma in children: Surgical lesions from a single institution and review of the literature. J Am Coll Surg 192:305–313PubMedCrossRefGoogle Scholar
  41. 41.
    Mauer HM, Beltangady M, Gerhan EA, et al. (1988) The Intergroup Rhabdomyosarcoma Study-1. A final report. Cancer 61:209–220CrossRefGoogle Scholar
  42. 42.
    Costa J, Westley RA, Glatstein E, et al. (1984) The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 53:530–541PubMedCrossRefGoogle Scholar
  43. 43.
    Fleming ID, Cooper SJ, Henson DE, et al. (1998) AJCC cancer staging handbook. Lippincott-Raven, PhiladelphiaGoogle Scholar
  44. 44.
    Guillou I, Coindre JM, Bonichon F, et al. (1997) Comparative study of the National Cancer Institute and French Federation of cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15:350–362PubMedGoogle Scholar
  45. 45.
    van Unnik JA, Coindre JM, Contesso C, et al. (1993) Grading of soft tissue sarcomas: Experience of the EORtTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 29A:2089–2093PubMedCrossRefGoogle Scholar
  46. 46.
    Coindre JM, Trojani M, Contesso G, et al. (1986) Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58:306–309PubMedCrossRefGoogle Scholar
  47. 47.
    Parham DM, Webber BI, Jenkins JJ III, et al. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: Formulation of a simplified system for grading. Mod Pathol 8(7):705–710Google Scholar
  48. 48.
    Rodriguez-Galindo C, Ramsey K, Jenkins JJ, et al. (2000) Hermangiopericytoma in children and infants. Cancer 88:198–204PubMedCrossRefGoogle Scholar
  49. 49.
    Loh MI, Ahn P, Perez-Atayde AR, et al. (2002) Treatment of infantile fibrosarcoma with chemotherapy and surgery: Results from the Dana-Farber Cancer Institute and children’s Hospital, Boston. J Pediatr Hematol Oncol 24:722–726PubMedCrossRefGoogle Scholar
  50. 50.
    Spunt SI, Poquette CA, Hurt YS, et al. (1999) Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St. Jude Children’s Research Hospital. J Clin Oncol 17:3697–3705PubMedGoogle Scholar
  51. 51.
    Marcus KC, Grier HE, Shamberger RC, et al. (1997) Childhood soft tissue sarcoma: A 20-year experience. J Pediatr 131:603–607PubMedCrossRefGoogle Scholar
  52. 52.
    Pratt CB, Pappo AS, Gieser P, et al. (1999) Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol 17:1219–1226PubMedGoogle Scholar
  53. 53.
    Stojadinovic A, Leung DH, Allen P, et al. (2002) Primary adult soft tissue sarcoma: Time-dependent influence of prognostic variables. J Clin Oncol 20:4344–4352PubMedCrossRefGoogle Scholar
  54. 54.
    Pappo AS, Rao BN, Jenkins JI, et al. (1999) Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children’s Research Hospital experience. Med Pediatr Oncol 33:76–82PubMedCrossRefGoogle Scholar
  55. 55.
    Spunt SI, Hill DA, Motosue AM, et al. (2000) Clinical features and outcome of children with unresected non-rhabdomyosarcoma soft tissue sarcoma (NRSTS). Med Pediatr Oncol 35:279 (abst)Google Scholar
  56. 56.
    Spunt SI, Hill DA, Motosue AM, et al. (2002) Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 20:3225–3235PubMedCrossRefGoogle Scholar
  57. 57.
    Butler MS, Robertson WW Jr, Rate W, et al. (1990) Skeletal sequelae of radiation therapy for malignant childhood tumors. Clin Orthop 25:235–240Google Scholar
  58. 58.
    Smith MD, Xue H, Strong L, et al. (1993) Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy. J Pediatr Surg 28:1342–1349PubMedCrossRefGoogle Scholar
  59. 59.
    Humpl T, Pritsche M, Bartels U, et al. (2001) survivors of childhood cancer for more than twenty years. Acta Oncol 40:44–49PubMedCrossRefGoogle Scholar
  60. 60.
    Feig SA (2001) Second malignant neoplasms after successful treatment of childhood cancers. Blood Cells Mol Dis 27:662–666PubMedCrossRefGoogle Scholar
  61. 61.
    Rich DC, Corpron CA, Smith MB, et al. (1997) Secondmalignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg 32:369–372PubMedCrossRefGoogle Scholar
  62. 62.
    Moller TR, Garwicz S, Barlow L, et al. (2001) Decreasing late mortality among five year survivors of cancer in childhood and adolescence: A population-based study in the Nordic counties. J Clin Oncol 19:3173–3181PubMedGoogle Scholar
  63. 63.
    Corpron CA, Black TC, Ross MI, etal. (1996) Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg 171:459–462CrossRefGoogle Scholar
  64. 64.
    Miller SD, Adrassy RJ (2003) Complications in pediatric surgical oncology. J Amer Col Surg 197:832–837CrossRefGoogle Scholar
  65. 65.
    Corpron CA, Black CT, Raney RB, et al. (1996) Malignant fibrous histiocytoma in children. J Pediatr Surg 31:1080–1083PubMedCrossRefGoogle Scholar
  66. 66.
    Smith MB, Katz R, Black CT, et al. (1993) A rational approach to the use of fine-needle aspiration biopsy in the evaluation of primary and recurrent neoplasms in children. J Pediatr Surg 28:1245–1247PubMedCrossRefGoogle Scholar
  67. 67.
    Blakely ML, Spurbeck WW, Pappo AS, et al. (1999) The impact of marginson? Outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 34:672–675PubMedCrossRefGoogle Scholar
  68. 68.
    Neville HL, Andrassy RJ, Lally KP, et al. (2000) Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg 35:961–964PubMedCrossRefGoogle Scholar
  69. 69.
    Pappo AS, Fontanesi J, Luo X, et al. (1994) Synovial sarcoma in children and adolescents: The St. Jude Children’s Research Hospital experience. J Clin Oncol 12:2660–2666Google Scholar
  70. 70.
    Brennan MF (1997) The enigma of local recurrence. Am Surg Oncol 2:1–12CrossRefGoogle Scholar
  71. 71.
    Muller JR, Zagars CK (1994) Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol 33:23–30CrossRefGoogle Scholar
  72. 72.
    Fontanesi J, Pappo AS, Parham DW, et al. (1996) Role of irradiation in management of synovial sarcoma: St. Judes Children’s Research Hospital experience. Med Pediatr Oncol 26:264–267PubMedCrossRefGoogle Scholar
  73. 73.
    Pappo AS, Parham DM, Rao BM, et al. (1999) Soft tissue sarcomas in children. Semin Surg Oncol 16:121–143PubMedCrossRefGoogle Scholar
  74. 74.
    Coffin CM, Dehner LP (1993) Vascular tumors in children and adolescents: A clinicopathologic study of 228 tumors in 222 patients. Pathol Ann 28:97–120Google Scholar
  75. 75.
    Fisher C (1990) The value of electromicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: A study of 200 cases. Histopathology 16:441–454PubMedGoogle Scholar
  76. 76.
    Coffin CM, Jaszez W, O’Shea PA, et al. (1994) So-called congenital infantile fibrosarcoma: Does it exist and what is it. Pediat Pathol 14:133–150CrossRefGoogle Scholar
  77. 77.
    Soule EH, Pritchard DJ (1977) Fibrosarcoma in infants and children: A review of 110 cases. Cancer 40:1711–1721PubMedCrossRefGoogle Scholar
  78. 78.
    Blocker S, Koenig J, Ternberg J (1987) Longenital fibrosarcoma. J Pediatr Surg 22:665–670PubMedCrossRefGoogle Scholar
  79. 79.
    Dobson I, Dickey LB (1956) Spontaneous regression of malignant tumors: Report of a twelve year spontaneous complete regression of an extensive fibrosarcoma with speculations about regression and dormancy. Am J Surg 92:162–173PubMedCrossRefGoogle Scholar
  80. 80.
    Barker D, Wright E, Nguyen L, et al. (1987) Gene for von Recklinghausen neurofibromatosis in the pericentromeric region of chromosome 17. Science 236:1100–1102PubMedCrossRefGoogle Scholar
  81. 81.
    Roulean GA, Wertelecki W, Haines JF, et al. (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246–248CrossRefGoogle Scholar
  82. 82.
    Riccardi VM (1981) Von Reckinghausen neurofibromatosis. N Engl J Med 305:1617PubMedGoogle Scholar
  83. 83.
    Ducatman BS, Scheitnauer BW, Peipgras DG, et al. (1986) Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases. Cancer 57:2006–20021PubMedCrossRefGoogle Scholar
  84. 84.
    DeCou JM, Rao BN, Parham DM, et al. (1995) Malignant peripheral nerve sheath tumors: The St. Jude Children’s Research Hospital experience 2:524–529Google Scholar
  85. 85.
    Raney R, Schnaufer I, Ziegler M, et al. (1987) Treatment of children with neurogenic sarcoma. Experience at the Children’s Hospital of Philadelphia, 1958–1984. Cancer 59:1–5PubMedCrossRefGoogle Scholar
  86. 86.
    Skotheim RI, Kallioniemi A, Bjerkhagen B, et al. (2003) Topoisomerase-11 alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. J Clin Oncol 21:4586–4591PubMedCrossRefGoogle Scholar
  87. 87.
    Doom PE, Molenaar WM, Buter J, et al. (1995) Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21:78–82CrossRefGoogle Scholar
  88. 88.
    Christopherson WM, Foote FW, Stewart FW (1952) Alveolar soft-part sarcoma: Structurally characteristic tumors of uncertain histogenesis. Cancer 5:100–111PubMedCrossRefGoogle Scholar
  89. 89.
    Yagihashi S (1992) Alveolar soft part sarcoma: Are we approaching the goal of determining its histogenesis? Acta Pathol Jpn 42:466–468PubMedGoogle Scholar
  90. 90.
    Portera CA Jr, Ho V, Patel SR, et al. (2001) Alveolar soft part sarcoma: Clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91:585–591PubMedCrossRefGoogle Scholar
  91. 91.
    Casanova M, Ferrar A, Bisogno G, et al. (2000) Alvelar soft part sarcoma in children and adolescents: A report from the soft-tissue sarcoma Italian Cooperative Group. Ann Oncol 11:1445–1449PubMedCrossRefGoogle Scholar
  92. 92.
    Raney RB (1979) Alveolar soft-part sarcoma. Med Pediatr Oncol 6:367–370PubMedCrossRefGoogle Scholar
  93. 93.
    Soule EH, Mahour GH, Mills SD, et al. (1968) Soft-tissue sarcomas of infants and children: A clinicopathologic study of 135 cases. Mayo Clin. Proc 43:313–326PubMedGoogle Scholar
  94. 94.
    Johnson H, Hutter H Jr, Paplanus SH (1980) Leiomyosarcoma of the stomach: Results of surgery and chemotherapy in an eleven-year old girl with liver metastasis. Med Pediatr Oncol 8:137–142PubMedCrossRefGoogle Scholar
  95. 95.
    LaQuaglia MP, Spiro SA, Ghovimi L, et al. (1993) Liprosarcoma in patients younger than or equal to 22 years of age. Cancer 72:3114–3119CrossRefGoogle Scholar
  96. 96.
    Ruymann FB (1987) Rhabdomyosarcoma in children and adolescents: A review. Hematol Oncol Clin North Am 1:621–654PubMedGoogle Scholar
  97. 97.
    Stout AP (1946) Rhabdomyosarcoma of the skeletal muscle. Ann Surg 123:447PubMedCrossRefGoogle Scholar
  98. 98.
    Pack GT, et al. Rhabdomyosarcoma of the skeletal muscle: Report of 100 cases. Surgery 32:1023–1952Google Scholar
  99. 99.
    Horn RC, et al. (1958) Rhabdomyosarcoma: A clinicopathological study and classification of 39 cases. Cancer 11:181–199PubMedCrossRefGoogle Scholar
  100. 100.
    Stobbe GC, et al. (1950) Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer 3:826PubMedCrossRefGoogle Scholar
  101. 101.
    Pinkel D, et al. (1961) Rhabdomyosarcoma in children. JAMA 175:293–298PubMedGoogle Scholar
  102. 102.
    Ruymann F, et al. (1988) Congenital anomalies associated with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoam Study. Med Pedatr Oncol 16:13Google Scholar
  103. 103.
    Hartley AN, et al. (1993) Patterns of cancer in the families of children with soft tissue sarcoma. Cancer 72:923–930PubMedCrossRefGoogle Scholar
  104. 104.
    Seymour-Dempsey K, et al. (2002) Neurofibromatosis: Implications for the general surgeon. J Am Coll Surg 195(4):553–561PubMedCrossRefGoogle Scholar
  105. 105.
    Li FP, et al. (1969) Soft tissue sarcomas, breast cancer and other neoplasms: A familial syndrome? Ann Intern Med 71:747–752PubMedGoogle Scholar
  106. 106.
    Li FP, et al. (1988) A cancer family syndrome in twentyfour kindreds. Cancer Res 48:5358–5362PubMedGoogle Scholar
  107. 107.
    Man dell LR, et al. (1989) The influence of extensive bone erosion on local control in non-orbital rhabdomyosarcoma of the head and neck. Int J Radiat Oncol Biol Phys 17:649–653Google Scholar
  108. 108.
    Strong LC, et al. (1992) The Li-Fraumeni Syndrome: From clinical epidemiology to molecular genetics. Am J Epidemiol 135:190–199PubMedGoogle Scholar
  109. 109.
    Birch JM, et al. (1984) Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer 49:325–331PubMedGoogle Scholar
  110. 110.
    Grufferman A, et al. In utero X-ray exposure and risk of childhood rhabdomyosarcoma. Society for Epidemiologic Research 4th Annual Meeting, Buffalo, New York, June 11, 1991Google Scholar
  111. 111.
    Grufferman S, et al. (1993) Parents use of recreational drugs and risk of rhabdomyosarcoma in their children. Cancer Causes Control 4:217–224PubMedGoogle Scholar
  112. 112.
    Rodeberg DA, et al. (2002) Surgical principles for children? Adolescents with newly diagnosed rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Sarcoma 6:111–122PubMedCrossRefGoogle Scholar
  113. 113.
    Dagher R, et al. (1999) Rhabdomyosarcoma: An overview. Oncologist 4:34–44PubMedGoogle Scholar
  114. 114.
    Li M, et al. (1997) Molecular genetics of Beckwith-Wiedemann Syndrome. Curr Opin Pediatr 9:623–629PubMedCrossRefGoogle Scholar
  115. 115.
    Morison IM, et al. (1998) Insulin-like growth factor 2 and overgrowth: Molecular biology and clinical implications. Mol Med Today 4:110–115PubMedCrossRefGoogle Scholar
  116. 116.
    Turc Carel C, et al. (1986) Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet CytoGenet 19:361–362PubMedCrossRefGoogle Scholar
  117. 117.
    Wexler LH, et al. (1994) Pediatric soft tissue sarcomas. Ca Cancer J Clin 44:211–247PubMedCrossRefGoogle Scholar
  118. 118.
    Leader M, et al. (1989) Myoglobin: An evaluation of its role as a marker of rhabdomyosarcomas. Br J Cancer 59:106–109PubMedGoogle Scholar
  119. 119.
    Weintraub H, et al. (1991) The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 251:761–766PubMedCrossRefGoogle Scholar
  120. 120.
    Tapscott SJ, et al. (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259:1450–1453PubMedCrossRefGoogle Scholar
  121. 121.
    Shapiro DN, et al. (1991) Relationship of tumor-cell ploidy to histologic subtype and treatment of outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 9:159–166PubMedGoogle Scholar
  122. 122.
    Kilpatrick SE, et al. (1994) Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Cancer 74:3227–3233PubMedCrossRefGoogle Scholar
  123. 123.
    Ferracini R, et al. (1996) Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12:1697–1705PubMedGoogle Scholar
  124. 124.
    Andrassy RJ, et al. (1999) Progress in the surgical management of vaginal rhabdomyosarcoma: A 25-Year Review From the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 34:731–735PubMedCrossRefGoogle Scholar
  125. 125.
    Asmar L, et al. (1994) Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: Report of an international study of four pathology classifications. Cancer 74:2579–2588PubMedCrossRefGoogle Scholar
  126. 126.
    Newton WA, et al. (1991) Pathology of rhabdomyosarcoma and related tumors. In: Maurer HM, Ruyman FB, Pochedly C (eds) Rhabdomyosarcoma and related tumors in children and adolescents. CRC Press, Boca RatonGoogle Scholar
  127. 127.
    Newton WA, et al. (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification. An intergroup rhabdomyosarcoma study. Cancer 76:1073–1085PubMedCrossRefGoogle Scholar
  128. 128.
    Wiener ES, et al. (2001) Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediat Surg 10:146–152CrossRefGoogle Scholar
  129. 129.
    Crist W, et al. (1995) Intergroup rhabdomyosarcoma study (IRS) III. J Clin Oncol 13:610–630PubMedGoogle Scholar
  130. 130.
    Raney RB Jr (1991) Rhabdomyosarcoma and related tumors of the head and neck in childhood. In: Maurer HM, Ruymann FB, Pochedly C (eds) Rhabdomyosarcoma and related tumors in children and adolescents. CRC, Boca RatonGoogle Scholar
  131. 131.
    Raney RB Jr, et al. (1987) Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: A report from the intergroup rhabdomyosarcoma study. Cancer 59:147–155PubMedCrossRefGoogle Scholar
  132. 132.
    Wharam M, et al. (1987) Management of orbital rhabdomyosarcoma. In Jacob C (ed) Cancers of the head and neck. Martinus Niijhoff, BostonGoogle Scholar
  133. 133.
    Andrassy RJ, et al. (1996) Extremity sarcomas: An analysis of prognostic factors from the intergroup rhabdomyosarcoma study (IRS) III. J Pediatr Surg31:191–196PubMedCrossRefGoogle Scholar
  134. 134.
    Neville HL, et al. (2000) Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997.) J Pediatr Surg 35:317–321PubMedCrossRefGoogle Scholar
  135. 135.
    Rodeberg D, et al. (2005) Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. J Pediatr Surg 40(1):256–262PubMedCrossRefGoogle Scholar
  136. 136.
    Lobe TE, et al. (1994) Neonatal rhabdomyosarcoma: The IRS experience. J Pediatr Surg 29:1167–1170PubMedCrossRefGoogle Scholar
  137. 137.
    Neville HL, et al. (2000) Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg 35:961–964PubMedCrossRefGoogle Scholar
  138. 138.
    Lawrence W Jr, et al. (1988) Surgical lessions from the intergroup rhabdomyosarcoma study (IRS) pertaining to extremity tumors. World J Surg 12:676–684PubMedCrossRefGoogle Scholar
  139. 139.
    Andrassy RJ (1997) Rhabdomyosarcoma. Semin Pediatr Surg 6:17–23PubMedGoogle Scholar
  140. 140.
    Crist WM, et al. (2001) Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3012PubMedGoogle Scholar
  141. 141.
    Raney RB, et al. (2001) The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major lessons from the IRS-I through IRS-IV studies as background for the current IRS-IV treatment protocols. Sarcoma 5:9–15PubMedGoogle Scholar
  142. 142.
    Hays DM, et al. (1989) Primary re-excision for patients with “microscopic residual” following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 24:5–10PubMedCrossRefGoogle Scholar
  143. 143.
    Cofer BR, et al. (1998) Rhabdomyosarcoma. In: Andrassy RJ (ed). Pediatric surgical oncology. WB Saunders, PhiladelphiaGoogle Scholar
  144. 144.
    Wiener ES, et al. (1991) Rhabdomyosarcoma in extremity and trunk sites. In: Maurer HM, Ruymann FB, Pochedly C (eds) Rhabdomyosarcoma and related tumors in children and adolescents. CRC Press, Boca RatonGoogle Scholar
  145. 145.
    Wiener ES (1993) Rhabdomyosarcoma: New dimensions in management. Semin Pediatr Surg 2:47–58PubMedGoogle Scholar
  146. 146.
    Wiener ES, et al. (for the IRS Committee of CCSG, POG, UKCCSG) (1990) Second look operations in children in group III and IV rhabdomyosarcoma (RMS). SIOP XXII Meeting, October, Rome. Med Pediatr Oncol 18:408Google Scholar
  147. 147.
    Wiener E, et al. (for the IRS Committee of CCSG and POG) (1991) Complete response or not complete response? Second look operations are the answer in children with rhabdomyosarcoma. ASCO Annual Meeting, May 19–21, 1991, Houston, Texas. Proc Am Soc Clin Oncol 10:316Google Scholar
  148. 148.
    Wolden SL, et al. (1999) Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies (IRS) I to III. J Clin Oncol 17:3468–3475PubMedGoogle Scholar
  149. 149.
    Wiener ES, et al. (1994) Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J Pediatr Surg 29:171–178PubMedCrossRefGoogle Scholar
  150. 150.
    Lawrence W Jr, et al. (1988) Surgical lesions from the intergroup rhabdomyosarcoma study (IRS) pertaining to extremity tumors. World J Surg 12:676–684PubMedCrossRefGoogle Scholar
  151. 151.
    Mandell L, et al. (1990) Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma. Med Pediatr Oncol 18:466–471PubMedCrossRefGoogle Scholar
  152. 152.
    Crist W, et al. (For the IRS Committee) (1990) Prognosis in children with rhabdomyosarcoma-A report of IRS-I and IRS-II. J Clin Oncol 8:443–452PubMedGoogle Scholar
  153. 153.
    Maurer HM, et al. (1988) The intergroup rhabdomyosarcoma study-I: A final report. Cancer 61:209–220PubMedCrossRefGoogle Scholar
  154. 154.
    Maurer HM, et al. (1993) The intergroup rhabdomyosarcoma study-II. Cancer 71:1904–1922PubMedCrossRefGoogle Scholar
  155. 155.
    Ruymann F, et al. (1997) Comparison of two doublet chemotherapy regimes and conventional radiotherapy in metastatic rhabdomyosarcoma: Improved overall survival using ifosfamide/etoposide compared to vincristine/melphalan in IRSG-IV. Proc Am Soc Clin Oncol 16:521aGoogle Scholar
  156. 156.
    Miser JS, et al. (1987) Ifosfamide with mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191–1198PubMedGoogle Scholar
  157. 157.
    Crist W, et al. (1999) Preliminary results for patients with local/regional tumors treated on the Intergroup Rhabdomyosarcoma Study-IV (1991–1997). Pro Am Soc Clin Oncol 18:18Google Scholar
  158. 158.
    Anderson GJ, et al. (1990) Rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg 116:428–431PubMedGoogle Scholar
  159. 159.
    Gross M, et al. (1988) Therapy of rhabdomyosarcoma of the larynx. Int J Pediatr Otorhinolaryngol 15:93–97PubMedCrossRefGoogle Scholar
  160. 160.
    Pappo AS, et al. (1997) A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. J Pediatr Hematol Oncol 19:438–442PubMedCrossRefGoogle Scholar
  161. 161.
    Pappo AS, et al. (2001) Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study (IRSG). J Clin Oncol 19:213–219PubMedGoogle Scholar
  162. 162.
    Vietti T, et al. (1997) Topotecan window in patients with rhabdomyosarcoma (RMS): An IRSG study. Proc Am Soc Clin Oncol 16:510aGoogle Scholar
  163. 163.
    Horowitz ME, et al. (1993) Total-body irradiation and autologous bone marrow transplant in the treatment of highrisk Ewing’s sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911–1918PubMedGoogle Scholar
  164. 164.
    Koscielniak E, et al. (1997) Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/ Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplan 19:227–231CrossRefGoogle Scholar
  165. 165.
    Furman W, et al. (1998) A Phase I study of irinotecan (CPT-11) in children with relapsed solid tumors. Proc Am Soc Clin Oncol 17:187aGoogle Scholar
  166. 166.
    Donaldson S, et al. (1995) Hyperfractionated radiation in children with rhabdomyosarcoma-Results of an intergroup rhabdomyosarcoma pilot study. Int J Radiat Oncol Biol Phys 32:903–911PubMedGoogle Scholar
  167. 167.
    Donaldson SS, et al. (2000) Results from the Intergroup Rhabdomyosarcoma Study-IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 48:178Google Scholar
  168. 168.
    Smith LM, et al. (2000) Which patients with rhabdomyosarcoma (RMS) and microscopic residual tumor (Group II) fail therapy? A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG). Proc Am Soc Clin Oncol 19:577aGoogle Scholar
  169. 169.
    Raney RB, et al. (2000) Results of treating localized cranial parameningeal sarcoma on Intergroup Rhabdomyosarcoma (RMS) Studies (IRS)-II through IV. Med Pediatric Oncol 35:178Google Scholar
  170. 170.
    Healy GB, et al. (1991) The role of surgery in rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg 117:1185–1188PubMedGoogle Scholar
  171. 171.
    Lawrence W Jr, et al. (1987) Lymphatic metastasis with childhood rhabdomyosarcoma. Cancer 60:910–915PubMedCrossRefGoogle Scholar
  172. 172.
    Coene IMJH, et al. (1992) Rhabdomyosarcoma of the head and neck in children. Clin Otolaryngol 17:291–296PubMedCrossRefGoogle Scholar
  173. 173.
    Wiener ES (1994) Head and neck rhabdomyosarcoma. Semin Pediatr Surg 3:203–206PubMedGoogle Scholar
  174. 174.
    Abramson DH, et al. (1979) The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy. Opthalmology 86:1330–1335Google Scholar
  175. 175.
    Fiorillo A, et al. (1991) Multidisciplinary treatment of primary orbital rhabdomyosarcoma: A single institution experience. Cancer 67:560–563PubMedCrossRefGoogle Scholar
  176. 176.
    Kao GD, et al. (1993) The sequellae of chemoradiation therapy for head and neck cancer in children: Managing impaired growth, development and other side effects. Med Pediatr Oncol 21:60–66PubMedCrossRefGoogle Scholar
  177. 177.
    Anderson JR, et al. (1998) Improved outcome for patients with embryonal histology but not alveolar histology rhabdomyosarcoma: Results from Intergroup Rhabdomyosarcoma Study IV (IRS-IV). Proc Soc Clin Oncol 17:526aGoogle Scholar
  178. 178.
    Gross M, et al. (1988) Therapy of rhabdomyosarcoma of the larynx. Int J Pediatr Otorhinolaryngol 15:93–97PubMedCrossRefGoogle Scholar
  179. 179.
    Malkin D, et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238PubMedCrossRefGoogle Scholar
  180. 180.
    Raney RB Jr, et al. (1978) Paratesticular rhabdomyosarcoma in children. Cancer 42:729–736PubMedCrossRefGoogle Scholar
  181. 181.
    Gasparini M, et al. (1990) Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma with meningeal extension. J Clin Oncol 8:1854–1857PubMedGoogle Scholar
  182. 182.
    Tefft M, et al. (1981) Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: Local control in patients enrolled into the intergroup rhabdomyosarcoma study. Natl Cancer Inst Monogr 56:75–81PubMedGoogle Scholar
  183. 183.
    Gilles R, et al. (1994) Head and neck rhabdomyosarcomas in children: Value of clinical and CT findings in the detection of local regional relapses. Clin Radiol 49:412–415PubMedCrossRefGoogle Scholar
  184. 184.
    Raney RB, et al. (For the 1RS Committee) (1980) Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus and cervix. A comparison of the results in intergroup rhabdomyosarcoma studies I and II. Cancer 66:2072–2081CrossRefGoogle Scholar
  185. 185.
    Raney B, et al. (1993) Sequelae of treatment in 109 patients followed from five to fifteen years after diagnosis of sarcoma of the bladder and prostate: A report from the intergroup rhabdomyosarcoma study (IRS) committee. Cancer 71:2387–2394PubMedCrossRefGoogle Scholar
  186. 186.
    Hays DM, et al. (1990) Partial cystectomy in the management of rhabdomyosarcoma of the bladder: A report from the intergroup rhabdomyosarcoma study. J Pediatr Surg 25:719–723PubMedCrossRefGoogle Scholar
  187. 187.
    Hays DM, et al. (1991) Retention of functional bladders among patients with vesicle/prostatic sarcomas in the intergroup rhabdomyosarcoma studies (IRS) (1978–1990). Med Pediatr Oncol 19:423 (abstr)Google Scholar
  188. 188.
    Hays D, et al. (1995) Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy, with neoadjuvant or adjuvant chemotherapy with or without radiotherapy. J Pediatr Hematol Oncol 17:46–52PubMedCrossRefGoogle Scholar
  189. 189.
    Heyn R, et al. (1997) Preservation of the Bladder in patients with rhabdomyosarcoma. J Clin Oncol 15:69–75PubMedGoogle Scholar
  190. 190.
    Lobe TE, et al. (1996) The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma. J Pediatr Surg 31:1084–1087PubMedCrossRefGoogle Scholar
  191. 191.
    Leuschner I, et al. (1993) Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: A report of the Inergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17:221–230PubMedCrossRefGoogle Scholar
  192. 192.
    Hamilton CR, et al. (1989) The management of paratesticular rhabdomyosarcoma. Clin Radiol 40:314–317PubMedCrossRefGoogle Scholar
  193. 193.
    Goldfarb B, et al. (1994) The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma. J Urol 152:785–787PubMedGoogle Scholar
  194. 194.
    Olive D, et al. (1984) Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma. Cancer 54:1283–1287PubMedCrossRefGoogle Scholar
  195. 195.
    Heyn R, et al. (for the IRS Study Committee) (1992) Late effects of therapy in patients with paratesticular rhabdomyosarcoma. J Clin Oncol 10:614–623PubMedGoogle Scholar
  196. 196.
    Wiener ES, et al. What is optimal management for children or adolescents with localized paratesticular rhabdomyosarcoma? Results in IRS-III and IRS-IV. J Pediatr Surg (in press)Google Scholar
  197. 197.
    Breneman JC, et al. (1996) The management of pediatric genitourinary rhabdomyosarcoma. In: Vogelzang NJ, et al (eds) The comprehensive textbook of genitourinary oncology. Williams & Wilkins, BaltimoreGoogle Scholar
  198. 198.
    Andrassy RJ, et al. (1995) Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study III. J Pediatr Surg 30:1034–1036PubMedCrossRefGoogle Scholar
  199. 199.
    Corpron CA, et al. (1995) Conservative management of uterine pediatric rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study III and IV Pilot. J Pediatr Surg 30:942–944PubMedCrossRefGoogle Scholar
  200. 200.
    Arndt CA, et al. (2001) What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 91:2454–2468PubMedCrossRefGoogle Scholar
  201. 201.
    Andrassy R, et al. (1998) Thoracic sarcomas in children. Ann Surg 227:170–173PubMedCrossRefGoogle Scholar
  202. 202.
    Raney B, et al. (for the IRS Committee) (1982) Soft-tissue sarcoma for the trunk in childhood: Results of the intergroup rhabdomyosarcoma study (IRS), 1972–1976. Cancer 49:2612–2616PubMedCrossRefGoogle Scholar
  203. 203.
    Beech TR, et al. (1999) What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 34:668–671PubMedCrossRefGoogle Scholar
  204. 204.
    Crist WM, et al. (1985) Soft tissue sarcomas arising in the retroperitoneal space in children. A report from the intergroup rhabdo-myosarcoma study. Cancer 56:2125–2132PubMedCrossRefGoogle Scholar
  205. 205.
    Blakely ML, et al. (1999) Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma? J Pediatr Surg 5:736–741CrossRefGoogle Scholar
  206. 206.
    Raney RB, et al. (2004) Results of treatment of 56 patients with localized retroperitoneal and Pelvic Rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study-IV, 1991–1997. Pediatr Blood Cancer 42:618–625PubMedCrossRefGoogle Scholar
  207. 207.
    Pollono DG, et al. (1998) Rhabdomyosarcoma of extrahepatic biliary tree: Initial treatment with chemotherapy and conservative surgery. Med Pediatr Oncol 30:290–293PubMedCrossRefGoogle Scholar
  208. 208.
    Spunt SL, et al. (2000) Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 35:309–316PubMedCrossRefGoogle Scholar
  209. 209.
    Blakely ML, et al. (2003) Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: A report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. J Pediatr Surg 38:347–353PubMedCrossRefGoogle Scholar
  210. 210.
    Neville HL, et al. (2000) Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg 35:317–321PubMedCrossRefGoogle Scholar
  211. 211.
    Andrassy RJ (2002) Advances in the surgical management of sarcomas in children. Am J Surg 184:484–491PubMedCrossRefGoogle Scholar
  212. 212.
    La Quaglia MP, et al. (1990) Factors predictive of mortality in pediatric extremity rhabdomyosarcoma. J Pediatr Surg 25:238–243CrossRefGoogle Scholar
  213. 213.
    Rich DC, et al. (1997) Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg 32:369–372PubMedCrossRefGoogle Scholar
  214. 214.
    Breneman JC, et al. (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-A report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21:78–84PubMedCrossRefGoogle Scholar
  215. 215.
    Hayes-Jordan A, Doherty DK, West SD, et al. (2006) Outcome after surgical resection of recurrent rhabdomyosarcoma. J Pediatr Surg 41:633–638PubMedCrossRefGoogle Scholar
  216. 216.
    Klingbiel T, Pertl U, Hess CE, et al. (1998) Treatment of children with relapsed soft tissue sarcoma: Report of the german CESS/CWS REZ 91 trial. Med Pediatr Oncol 30:269–275CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Richard J. Andrassy
    • 1
  1. 1.Department of SurgeryUniversity of Texas Medical CenterHoustonUSA

Personalised recommendations